Cargando…
Correction to: Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
Autores principales: | Zhou, Ping, Qin, Jiaqi, Li, Yuan, Li, Guoxia, Wang, Yinsong, Zhang, Ning, Chen, Peng, Li, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923813/ https://www.ncbi.nlm.nih.gov/pubmed/33648517 http://dx.doi.org/10.1186/s13046-021-01885-y |
Ejemplares similares
-
Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis
por: Zhou, Ping, et al.
Publicado: (2017) -
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018) -
O-GlcNAc on PKCζ Inhibits the FGF4-PKCζ-MEK-ERK1/2 Pathway via Inhibition of PKCζ Phosphorylation in Mouse Embryonic Stem Cells
por: Miura, Taichi, et al.
Publicado: (2017) -
Association of PKCζ Expression with Clinicopathological Characteristics of Breast Cancer
por: Yin, Jian, et al.
Publicado: (2014) -
Spheciosterol Sulfates, PKCζ Inhibitors from a Philippine Sponge Spheciospongia sp.
por: Whitson, Emily L., et al.
Publicado: (2008)